These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 32088858)
41. World War against COVID-19: How strong is our armamentarium? Ramachandran V; Marimuthu RR; Chinnambedu RS Med J Malaysia; 2020 May; 75(3):314-315. PubMed ID: 32467555 [TBL] [Abstract][Full Text] [Related]
42. Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection? Severa M; Farina C; Salvetti M; Coccia EM Front Immunol; 2020; 11():1459. PubMed ID: 32655578 [No Abstract] [Full Text] [Related]
43. The Wuhan SARS-CoV-2-What's next for China. Lu H; Stratton CW; Tang YW J Med Virol; 2020 Jun; 92(6):546-547. PubMed ID: 32115732 [No Abstract] [Full Text] [Related]
44. Perspective on the COVID-19 Coronavirus Outbreak. Lushington GH Comb Chem High Throughput Screen; 2020; 23(2):90-91. PubMed ID: 32284037 [No Abstract] [Full Text] [Related]
45. COVID-2019: update on epidemiology, disease spread and management. Sahu KK; Mishra AK; Lal A Monaldi Arch Chest Dis; 2020 Apr; 90(1):. PubMed ID: 32297723 [TBL] [Abstract][Full Text] [Related]
46. How likely are COVID-19 interventions to benefit the sickest patients? Perner A; Tirupakuzhi Vijayaraghavan BK; Venkatesh B Intensive Care Med; 2020 Jul; 46(7):1441-1444. PubMed ID: 32519004 [No Abstract] [Full Text] [Related]
47. Cutaneous sıde-effects of the potential COVID-19 drugs. Türsen Ü; Türsen B; Lotti T Dermatol Ther; 2020 Jul; 33(4):e13476. PubMed ID: 32358890 [TBL] [Abstract][Full Text] [Related]
48. Experts Discuss COVID-19-Remdesivir, Vaccines, and More. JAMA; 2020 Aug; 324(8):730-731. PubMed ID: 32777002 [No Abstract] [Full Text] [Related]
49. Investigating hypothiocyanite against SARS-CoV-2. Cegolon L Int J Hyg Environ Health; 2020 Jun; 227():113520. PubMed ID: 32305009 [No Abstract] [Full Text] [Related]
54. Thalidomide Should Be Tested as a Therapeutic Option in COVID-19 Pneumonia. Tiscornia JE; Poggio TV; Feinsilber DG; Coleman AE Skinmed; 2020; 18(4):254-255. PubMed ID: 33050993 [No Abstract] [Full Text] [Related]
55. Foreword for the special issue advances in COVID-19: Biology and clinic. McCubrey JA; Akula SM; Payrastre B Adv Biol Regul; 2020 Aug; 77():100744. PubMed ID: 32773104 [No Abstract] [Full Text] [Related]
56. Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19. Khalili JS; Zhu H; Mak NSA; Yan Y; Zhu Y J Med Virol; 2020 Jul; 92(7):740-746. PubMed ID: 32227493 [TBL] [Abstract][Full Text] [Related]
57. The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale. Schluger NW Ann Intern Med; 2020 Oct; 173(8):662-663. PubMed ID: 32673059 [TBL] [Abstract][Full Text] [Related]
58. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?]. Nisole S; Saulnier A; Gatignol A Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548 [No Abstract] [Full Text] [Related]
59. Treatments for COVID-19: where are we now? Mendes A Br J Community Nurs; 2020 Aug; 25(8):412-413. PubMed ID: 32757900 [No Abstract] [Full Text] [Related]
60. Traditional Chinese and Western Medicines Jointly Beat COVID-19 Pandemic. Qing GC; Zhang H; Bai Y; Luo Y Chin J Integr Med; 2020 Jun; 26(6):403-404. PubMed ID: 32361935 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]